Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2016, Article ID 9797410, 10 pages
http://dx.doi.org/10.1155/2016/9797410
Review Article

The Emerging Role of miRNAs and Their Clinical Implication in Biliary Tract Cancer

1Núcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém, PA, Brazil
2Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, PA, Brazil
3Universidade Federal de São Paulo, São Paulo, SP, Brazil

Received 22 July 2016; Revised 7 October 2016; Accepted 4 December 2016

Academic Editor: Mario Scartozzi

Copyright © 2016 Nina Nayara Ferreira Martins et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. H. Yoo, N. K. D. Kim, W. I. Kwon et al., “Genomic alterations in biliary tract cancer using targeted sequencing,” Translational Oncology, vol. 9, no. 3, pp. 173–178, 2016. View at Publisher · View at Google Scholar
  2. K. K. Ciombor and L. W. Goff, “Advances in the management of biliary tract cancers,” Clinical Advances in Hematology and Oncology, vol. 11, no. 1, pp. 28–34, 2013. View at Google Scholar · View at Scopus
  3. C. O. Gigek, E. S. Chen, D. Q. Calcagno, F. Wisnieski, R. R. Burbano, and M. A. C. Smith, “Epigenetic mechanisms in gastric cancer,” Epigenomics, vol. 4, no. 3, pp. 279–294, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Q. Calcagno, M. D. A. Cardoso Smith, and R. R. Burbano, “Cancer type-specific epigenetic changes: gastric cancer,” Methods in Molecular Biology, vol. 1238, pp. 79–101, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Saumet and C.-H. Lecellier, “MicroRNAs and personalized medicine: evaluating their potential as cancer biomarkers,” Advances in Experimental Medicine and Biology, vol. 888, pp. 5–15, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Huo, W. M. Clayton, T. F. Yoshimatsu, J. Chen, and O. I. Olopade, “Identification of a circulating MicroRNA signature to distinguish recurrence in breast cancer patients,” Oncotarget, 2016. View at Publisher · View at Google Scholar
  7. G. Yang, L. Zhang, R. Li, and L. Wang, “The role of microRNAs in gallbladder cancer (Review),” Molecular and Clinical Oncology, vol. 5, no. 1, pp. 7–13, 2016. View at Publisher · View at Google Scholar
  8. Y. Lee, M. Kim, J. Han et al., “MicroRNA genes are transcribed by RNA polymerase II,” EMBO Journal, vol. 23, no. 20, pp. 4051–4060, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Lin and R. I. Gregory, “MicroRNA biogenesis pathways in cancer,” Nature Reviews Cancer, vol. 15, no. 6, pp. 321–333, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Weber, “MicroRNAs: from basic mechanisms to clinical application in cardiovascular medicine,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 33, no. 2, pp. 168–169, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Zhang, J. Jiao, S. Cermelli et al., “miR-21 inhibition reduces liver fibrosis and prevents tumor development by inducing apoptosis of CD24+ progenitor cells,” Cancer Research, vol. 75, no. 9, pp. 1859–1867, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. Q. He, L. Cai, L. Shuai et al., “Ars2 is overexpressed in human cholangiocarcinomas and its depletion increases PTEN and PDCD4 by decreasing microRNA-21,” Molecular Carcinogenesis, vol. 52, no. 4, pp. 286–296, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. Z. Liu, Z.-Y. Jin, C.-H. Liu, F. Xie, X.-S. Lin, and Q. Huang, “MicroRNA-21 regulates biological behavior by inducing EMT in human cholangiocarcinoma,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 5, pp. 4684–4694, 2015. View at Google Scholar · View at Scopus
  14. F. Meng, R. Henson, M. Lang et al., “Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines,” Gastroenterology, vol. 130, no. 7, pp. 2113–2129, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Yang, X. Wang, W. Zheng, K. Li, H. Liu, and Y. Sun, “Genetic and epigenetic alterations are involved in the regulation of TPM1 in cholangiocarcinoma,” International Journal of Oncology, vol. 42, no. 2, pp. 690–698, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Lu, K. Byrnes, C. Han, Y. Wang, and T. Wu, “MiR-21 targets 15-PGDH and promotes cholangiocarcinoma growth,” Molecular Cancer Research, vol. 12, no. 6, pp. 890–900, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Chusorn, N. Namwat, W. Loilome et al., “Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis,” Tumor Biology, vol. 34, no. 3, pp. 1579–1588, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. F. M. Selaru, A. V. Olaru, T. Kan et al., “MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3,” Hepatology, vol. 49, no. 5, pp. 1595–1601, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. C.-Z. Liu, W. Liu, Y. Zheng et al., “PTEN and PDCD4 are bona fide targets of microRNA-21 in human cholangiocarcinoma,” Chinese Medical Sciences Journal, vol. 27, no. 2, pp. 65–72, 2012. View at Google Scholar · View at Scopus
  20. J. He, Y. Yue, C. Dong, and S. Xiong, “MiR-21 confers resistance against CVB3-induced myocarditis by inhibiting PDCD4-mediated apoptosis,” Clinical and Investigative Medicine, vol. 36, no. 2, pp. E103–E111, 2013. View at Google Scholar · View at Scopus
  21. N. Namwat, P. Chusorn, W. Loilome et al., “Expression profiles of oncomir miR-21 and tumor suppressor let-7a in the progression of opisthorchiasis-associated cholangiocarcinoma,” Asian Pacific Journal of Cancer Prevention, vol. 13, supplement, pp. 65–69, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. Q. Huang, L. Liu, C.-H. Liu et al., “MicroRNA-21 Regulates the invasion and metastasis in cholangiocarcinoma and may be a potential biomarker for cancer prognosis,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 2, pp. 829–834, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Karakatsanis, I. Papaconstantinou, M. Gazouli, A. Lyberopoulou, G. Polymeneas, and D. Voros, “Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance,” Molecular Carcinogenesis, vol. 52, no. 4, pp. 297–303, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Chang, J. Yang, G. Liu et al., “MiR-20a triggers metastasis of gallbladder carcinoma,” Journal of Hepatology, vol. 59, no. 3, pp. 518–527, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Yang, T. W. H. Li, J. Peng et al., “A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression,” Gastroenterology, vol. 141, no. 1, pp. 378.e4–388.e4, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Jin, Y. Xiang, J. Tang et al., “miR-34 is associated with poor prognosis of patients with gallbladder cancer through regulating telomere length in tumor stem cells,” Tumor Biology, vol. 35, no. 2, pp. 1503–1510, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Qiu, X. Luo, T. Kan et al., “TGF-β upregulates miR-182 expression to promote gallbladder cancer metastasis by targeting CADM1,” Molecular BioSystems, vol. 10, no. 3, pp. 679–685, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Peng, J. Jiang, Y. Yu et al., “Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis,” British Journal of Cancer, vol. 109, no. 12, pp. 3092–3104, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Braconi, N. Huang, and T. Patel, “Microrna-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes,” Hepatology, vol. 51, no. 3, pp. 881–890, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Hu, F. Huang, G. Deng, W. Nie, W. Huang, and X. Zeng, “miR-31 promotes oncogenesis in intrahepatic cholangiocarcinoma cells via the direct suppression of RASA1,” Experimental and Therapeutic Medicine, vol. 6, no. 5, pp. 1265–1270, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Meng, H. Wehbe-Janek, R. Henson, H. Smith, and T. Patel, “Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes,” Oncogene, vol. 27, no. 3, pp. 378–386, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. J. L. Mott, S. Kurita, S. C. Cazanave, S. F. Bronk, N. W. Werneburg, and M. E. Fernandez-Zapico, “Transcriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NF-kappaB,” Journal of Cellular Biochemistry, vol. 110, no. 5, pp. 1155–1164, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Zhang, C. Han, H. Zhu, K. Song, and T. Wu, “MiR-101 inhibits cholangiocarcinoma angiogenesis through targeting vascular endothelial growth factor (VEGF),” American Journal of Pathology, vol. 182, no. 5, pp. 1629–1639, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. Q. Wang, H. Tang, S. Yin, and C. Dong, “Downregulation of microRNA-138 enhances the proliferation, migrationand invasion of cholangiocarcinoma cells through the upregulation of RhoC/p-ERK/MMP-2/MMP-9,” Oncology Reports, vol. 29, no. 5, pp. 2046–2052, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Iwaki, K. Kikuchi, Y. Mizuguchi et al., “MiR-376c down-regulation accelerates EGF-dependent migration by targeting GRB2 in the HuCCT1 human intrahepatic cholangiocarcinoma cell line,” PLoS ONE, vol. 8, no. 7, Article ID e69496, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Zeng, Z. Li, R. Chen et al., “Epigenetic regulation of miR-124 by Hepatitis C Virus core protein promotes migration and invasion of intrahepatic cholangiocarcinoma cells by targeting SMYD3,” FEBS Letters, vol. 586, no. 19, pp. 3271–3278, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. Y.-H. Qiu, Y.-P. Wei, N.-J. Shen et al., “MiR-204 Inhibits epithelial to mesenchymal transition by targeting slug in intrahepatic cholangiocarcinoma cells,” Cellular Physiology and Biochemistry, vol. 32, no. 5, pp. 1331–1341, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. B. Li, Q. Han, Y. Zhu, Y. Yu, J. Wang, and X. Jiang, “Down-regulation of miR-214 contributes to intrahepatic cholangiocarcinoma metastasis by targeting Twist,” FEBS Journal, vol. 279, no. 13, pp. 2393–2398, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. N. Oishi, M. R. Kumar, S. Roessler et al., “Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma,” Hepatology, vol. 56, no. 5, pp. 1792–1803, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Okamoto, K. Miyoshi, and Y. Murawaki, “miR-29b, miR-205 and miR-221 enhance chemosensitivity to gemcitabine in HuH28 human cholangiocarcinoma cells,” PLoS ONE, vol. 8, no. 10, Article ID e77623, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Kono, M. Nakamura, T. Ohtsuka et al., “High expression of microRNA-155 is associated with the aggressive malignant behavior of gallbladder carcinoma,” Oncology reports, vol. 30, no. 1, pp. 17–24, 2013. View at Google Scholar · View at Scopus
  42. M.-Z. Ma, C.-X. Li, Y. Zhang et al., “Long non-coding RNA HOTAIR, a c-Myc activated driver of malignancy, negatively regulates miRNA-130a in gallbladder cancer,” Molecular Cancer, vol. 13, no. 1, article no. 156, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Zhou, W. Guo, Y. Zhao et al., “MicroRNA-26a acts as a tumor suppressor inhibiting gallbladder cancer cell proliferation by directly targeting HMGA2,” International Journal of Oncology, vol. 45, no. 6, pp. 2050–2058, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Zhou, W. Guo, Y. Zhao et al., “MicroRNA-135a acts as a putative tumor suppressor by directly targeting very low density lipoprotein receptor in human gallbladder cancer,” Cancer Science, vol. 105, no. 8, pp. 956–965, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. M.-Z. Ma, B.-F. Chu, Y. Zhang et al., “Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p,” Cell Death and Disease, vol. 6, no. 1, Article ID e1583, 2015. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Cai, L. Xu, Z. Cai, J. Wang, B. Zhou, and H. Hu, “MicroRNA-146b-5p inhibits the growth of gallbladder carcinoma by targeting epidermal growth factor receptor,” Molecular Medicine Reports, vol. 12, no. 1, pp. 1549–1555, 2015. View at Publisher · View at Google Scholar · View at Scopus
  47. G. Li and Y. Pu, “MicroRNA signatures in total peripheral blood of gallbladder cancer patients,” Tumor Biology, vol. 36, no. 9, pp. 6985–6990, 2015. View at Publisher · View at Google Scholar · View at Scopus
  48. T. Kitamura, K. Connolly, L. Ruffino et al., “The therapeutic effect of histone deacetylase inhibitor PCI-24781 on gallbladder carcinoma in BK5.erbB2 mice,” Journal of Hepatology, vol. 57, no. 1, pp. 84–91, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. L.-J. Wang, C.-C. He, X. Sui et al., “MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN,” Oncotarget, vol. 6, no. 8, pp. 5932–5946, 2015. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Sekine, Y. Shimada, T. Nagata et al., “Role of aquaporin-5 in gallbladder carcinoma,” European Surgical Research, vol. 51, no. 3-4, pp. 108–117, 2013. View at Publisher · View at Google Scholar
  51. R. Bao, Y. Shu, Y. Hu et al., “miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and smad pathways in gallbladder carcinoma,” Oncotarget, 2016. View at Publisher · View at Google Scholar
  52. P. Y. Wu, X. D. Zhang, J. Zhu, X. Y. Guo, and J. F. Wang, “Low expression of microRNA-146b-5p and microRNA-320d predicts poor outcome of large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone,” Human Pathology, vol. 45, no. 8, pp. 1664–1673, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. C. Shen, H. Yang, H. Liu, X. Wang, Y. Zhang, and R. Xu, “Inhibitory effect and mechanisms of microRNA-146b-5p on the proliferation and metastatic potential of Caski human cervical cancer cells,” Molecular Medicine Reports, vol. 11, no. 5, pp. 3955–3961, 2015. View at Publisher · View at Google Scholar · View at Scopus
  54. Z. Dang, W.-H. Xu, P. Lu et al., “MicroRNA-135a inhibits cell proliferation by targeting Bmi1 in pancreatic ductal adenocarcinoma,” International Journal of Biological Sciences, vol. 10, no. 7, pp. 733–745, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. J.-Y. Shin, Y.-I. Kim, S.-J. Cho et al., “MicroRNA 135a suppresses lymph node metastasis through down-regulation of ROCK1 in early gastric cancer,” PLoS ONE, vol. 9, no. 1, Article ID e85205, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. W. Tang, Y. Jiang, X. Mu, L. Xu, W. Cheng, and X. Wang, “MiR-135a functions as a tumor suppressor in epithelial ovarian cancer and regulates HOXA10 expression,” Cellular Signalling, vol. 26, no. 7, pp. 1420–1426, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. I. Igaz and P. Igaz, “Diagnostic relevance of microRNAs in other body fluids including urine, feces, and saliva,” EXS, vol. 106, pp. 245–252, 2015. View at Google Scholar
  58. F. Bernuzzi, F. Marabita, A. Lleo et al., “Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma,” Clinical & Experimental Immunology, vol. 185, no. 1, pp. 61–71, 2016. View at Publisher · View at Google Scholar
  59. K. Piontek and F. M. Selaru, “MicroRNAs in the biology and diagnosis of cholangiocarcinoma,” Seminars in Liver Disease, vol. 35, no. 1, pp. 55–62, 2015. View at Publisher · View at Google Scholar · View at Scopus
  60. P. Letelier, I. Riquelme, A. Hernández, N. Guzmán, J. Farías, and J. Roa, “Circulating MicroRNAs as biomarkers in biliary tract cancers,” International Journal of Molecular Sciences, vol. 17, no. 5, p. 791, 2016. View at Publisher · View at Google Scholar
  61. K. Shigehara, S. Yokomuro, O. Ishibashi et al., “Real-time PCR-based analysis of the human bile micrornaome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer,” PLoS ONE, vol. 6, no. 8, Article ID e23584, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. T. Kishimoto, H. Eguchi, H. Nagano et al., “Plasma miR-21 is a novel diagnostic biomarker for biliary tract cancer,” Cancer Science, vol. 104, no. 12, pp. 1626–1631, 2013. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Wang, J. Yin, T. Li et al., “Upregulated circulating miR-150 is associated with the risk of intrahepatic cholangiocarcinoma,” Oncology Reports, vol. 33, no. 2, pp. 819–825, 2015. View at Publisher · View at Google Scholar
  64. Q. Cheng, F. Feng, L. Zhu et al., “Circulating miR-106a is a novel prognostic and lymph node metastasis indicator for cholangiocarcinoma,” Scientific Reports, vol. 5, Article ID 16103, 2015. View at Publisher · View at Google Scholar · View at Scopus
  65. T. Voigtländer, S. K. Gupta, S. Thum et al., “MicroRNAs in serum and bile of patients with primary sclerosing cholangitis and/or cholangiocarcinoma,” PLoS ONE, vol. 10, no. 10, Article ID e0139305, 2015. View at Publisher · View at Google Scholar · View at Scopus
  66. R. Silakit, W. Loilome, P. Yongvanit et al., “Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator,” Journal of Hepato-Biliary-Pancreatic Sciences, vol. 21, no. 12, pp. 864–872, 2014. View at Publisher · View at Google Scholar · View at Scopus
  67. J. Plieskatt, G. Rinaldi, Y. Feng et al., “A microRNA profile associated with Opisthorchis viverrini-induced cholangiocarcinoma in tissue and plasma,” BMC Cancer, vol. 15, no. 1, article no. 309, 2015. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Kojima, H. Sudo, J. Kawauchi et al., “MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers,” PLoS ONE, vol. 10, no. 2, Article ID e0118220, 2015. View at Publisher · View at Google Scholar · View at Scopus
  69. A. Chandra, A. Ray, S. Senapati, and R. Chatterjee, “Genetic and epigenetic basis of psoriasis pathogenesis,” Molecular Immunology, vol. 64, no. 2, pp. 313–323, 2015. View at Publisher · View at Google Scholar · View at Scopus
  70. A. Gupta, A. Sharma, A. Yadav et al., “Evaluation of miR-27a, miR-181a, and miR-570 genetic variants with gallbladder cancer susceptibility and treatment outcome in a north indian population,” Molecular Diagnosis and Therapy, vol. 19, no. 5, pp. 317–327, 2015. View at Publisher · View at Google Scholar · View at Scopus
  71. Q. Sun, H. Gu, Y. Zeng et al., “Hsa-mir-27a genetic variant contributes to gastric cancer susceptibility through affecting miR-27a and target gene expression,” Cancer Science, vol. 101, no. 10, pp. 2241–2247, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. J. Xu, Z. Yin, H. Shen et al., “A genetic polymorphism in pre-miR-27a confers clinical outcome of non-small cell lung cancer in a Chinese population,” PLoS ONE, vol. 8, no. 11, Article ID e79135, 2013. View at Publisher · View at Google Scholar · View at Scopus
  73. Z. Wang, J. Lai, Y. Wang, W. Nie, and X. Guan, “The Hsa-miR-27a rs895819 (A>G) polymorphism and cancer susceptibility,” Gene, vol. 521, no. 1, pp. 87–90, 2013. View at Publisher · View at Google Scholar · View at Scopus
  74. Y. Lin, Y. Nie, J. Zhao et al., “Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility,” Carcinogenesis, vol. 33, no. 12, pp. 2377–2383, 2012. View at Publisher · View at Google Scholar · View at Scopus
  75. J.-Y. Ma, H.-J. Yan, Z.-H. Yang, and W. Gu, “Rs895819 within miR-27a might be involved in development of non small cell lung cancer in the Chinese Han population,” Asian Pacific Journal of Cancer Prevention, vol. 16, no. 5, pp. 1939–1944, 2015. View at Publisher · View at Google Scholar · View at Scopus
  76. Z. Wang, X. Sun, Y. Wang, X. Liu, Y. Xuan, and S. Hu, “Association between miR-27a genetic variants and susceptibility to colorectal cancer,” Diagnostic Pathology, vol. 9, no. 1, article no. 146, 2014. View at Publisher · View at Google Scholar · View at Scopus
  77. Y. Deng, H. Bai, and H. Hu, “rs11671784 G/A variation in miR-27a decreases chemo-sensitivity of bladder cancer by decreasing miR-27a and increasing the target RUNX-1 expression,” Biochemical and Biophysical Research Communications, vol. 458, no. 2, pp. 321–327, 2015. View at Publisher · View at Google Scholar · View at Scopus
  78. D. Shi, P. Li, L. Ma et al., “A genetic variant in pre-miR-27a is associated with a reduced renal cell cancer risk in a Chinese population,” PLoS ONE, vol. 7, no. 10, Article ID e46566, 2012. View at Publisher · View at Google Scholar · View at Scopus
  79. K. Srivastava, A. Srivastava, and B. Mittal, “Common genetic variants in pre-microRNAs and risk of gallbladder cancer in North Indian population,” Journal of Human Genetics, vol. 55, no. 8, pp. 495–499, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. F. Mihalache, A. Höblinger, M. Acalovschi, T. Sauerbruch, F. Lammert, and V. Zimmer, “A common variant in the precursor miR-146a sequence does not predispose to cholangiocarcinoma in a large european cohort,” Hepatobiliary and Pancreatic Diseases International, vol. 11, no. 4, pp. 412–417, 2012. View at Publisher · View at Google Scholar · View at Scopus
  81. A. Shinozaki, T. Sakatani, T. Ushiku et al., “Downregulation of MicroRNA-200 in EBV-associated gastric carcinoma,” Cancer Research, vol. 70, no. 11, pp. 4719–4727, 2010. View at Publisher · View at Google Scholar · View at Scopus
  82. M. Zhou, Z. Liu, Y. Zhao et al., “MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression,” Journal of Biological Chemistry, vol. 285, no. 28, pp. 21496–21507, 2010. View at Publisher · View at Google Scholar · View at Scopus
  83. C.-C. Lin, W. Jiang, R. Mitra, F. Cheng, H. Yu, and Z. Zhao, “Regulation rewiring analysis reveals mutual regulation between STAT1 and miR-155-5p in tumor immunosurveillance in seven major cancers,” Scientific Reports, vol. 5, Article ID 12063, 2015. View at Publisher · View at Google Scholar · View at Scopus
  84. J. H. Hwang, J. Voortman, E. Giovannetti et al., “Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer,” PLoS ONE, vol. 5, no. 5, Article ID e10630, 2010. View at Publisher · View at Google Scholar · View at Scopus